SELB News and Press, Selecta Biosciences Inc. From 07/09/23

2023-07-09 18:15:18 ET Acumen Pharmaceuticals ( NASDAQ: ABOS ), Establishment Labs ( NASDAQ: ESTA ), Arcus Biosciences ( NYSE: RCUS ) and BridgeBio Pharma ( NASDAQ: BBIO ) are four of BTIG's top picks for small and mid-cap healthcare stocks going into the lat...

- Phase 3 DISSOLVE I and DISSOLVE II studies both met their primary efficacy endpoints, with SEL-212-treated patients demonstrating statistically significant higher response rates compared to placebo - - SEL-212 was observed to have a favorable safety profile and was well-tolerated acro...

2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...

2023-05-04 19:06:14 ET Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Conference Call May 04, 2023, 08:30 ET Company Participants Blaine Davis - CFO Carsten Brunn - CEO, President & Director Peter Traber - Chief Medical Officer Conference Call Partic...

2023-05-04 07:50:06 ET Selecta Biosciences press release ( NASDAQ: SELB ): Q1 GAAP EPS of -$0.14 misses by $0.05 . Revenue of $5.9M (-82.6% Y/Y) misses by $6.24M . $127.5 million in cash, cash equivalents, restricted cash, and marketable securities as of...

- Company to implement capital prioritization initiative, extending cash runway to 2H-2025 - - $127.5 million in cash, cash equivalents, restricted cash, and marketable securities as of March 31, 2023 - - Reported positive data from Phase 3 DISSOLVE program of SEL-212 ...

WATERTOWN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies for autoimmune diseases and gene therapies, today  announced that it plans ...

2023-04-18 17:26:02 ET Summary After one month, the coffee can small cap portfolio has 14 stocks up and 12 stocks down. The biggest gainer over one month was JAKKS Pacific with a 45.8% gain. The biggest drag was Co-Diagnostics with a 43.66% decrease. The coffee can p...

2023-04-08 10:00:00 ET Summary Selecta Biosciences recently announced the results of its DISSOLVE I & II Phase 3 clinical trials for SEL-212, a combination therapy for chronic refractory gout patients. The trials met their primary endpoints, but SEL-212's performance did not c...

2023-03-21 09:01:38 ET Investing in penny stocks can be highly rewarding, but it also comes with significant risks. The high-risk, high-reward nature of penny stocks means potential for significant returns. But they can also lose their entire investment if the stock’s price drops...